Steven Kiel

Steven Kiel

Creator
0 followers

Founder/CIO at Arquitos Capital; shares small/micro-cap investing lessons, letters, and idea frameworks.

Biotech Liquidation Opportunities: ENDI, FNCH, LQDA Outlook
SocialApr 30, 2026

Biotech Liquidation Opportunities: ENDI, FNCH, LQDA Outlook

Please find Arquitos Capital's Q1 2026 letter below. I discuss opportunities in liquidating biotechs, $ENDI $FNCH and the range of potential outcomes for $LQDA. https://t.co/LJCczZ04W6

By Steven Kiel